(Q40461214)

English

The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection.

scientific article published on 8 November 2016

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

1 reference

Europe PubMed Central

The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection. (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

meningococcal disease

1 reference

based on heuristic

inferred from title

Anne von Gottberg

18

object named as

Anne von Gottberg

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

1

object named as

Ray Borrow

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Muhamed-Kheir Taha

15

object named as

Muhamed-Kheir Taha

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Dominique A Caugant

4

object named as

Dominique A Caugant

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

author name string

Pedro Alarcón

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Josefina Carlos

3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Hannah Christensen

5

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Roberto Debbag

6

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Philippe De Wals

7

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Gabriela Echániz-Aviles

8

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Jamie Findlow

9

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Chris Head

10

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Daphne Holt

11

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Hajime Kamiya

12

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Samir K Saha

13

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Sergey Sidorenko

14

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Caroline Trotter

16

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Julio A Vázquez Moreno

17

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Marco A P Sáfadi

19

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Global Meningococcal Initiative

20

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

8 November 2016

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Expert Review of Vaccines

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

313-328

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

AN ANALYSIS OF FOUR HUNDRED CASES OF EPIDEMIC MENINGITIS TREATED WITH THE ANTI-MENINGITIS SERUM.

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Meningococcal disease: history, epidemiology, pathogenesis, clinical manifestations, diagnosis, antimicrobial susceptibility and prevention

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

An epidemiological review of changes in meningococcal biology during the last 100 years

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Meningococcal Disease: The Organism, Clinical Presentation, and Worldwide Epidemiology

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Meningococcal conjugate vaccines: efficacy and new combinations.

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Impact of vaccination on meningococcal epidemiology

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Meningococcal disease: clinical presentation and sequelae.

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

The Global Meningococcal Initiative: recommendations for reducing the global burden of meningococcal disease.

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Hospital-based surveillance of meningococcal meningitis in Salvador, Brazil

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Neisseria meningitidis: an overview of the carriage state

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Meningococcal carriage by age: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Meningococcal carriage in the African meningitis belt

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Meningococcal carriage and disease--population biology and evolution

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Neisseria meningitidis; clones, carriage, and disease

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

The changing and dynamic epidemiology of meningococcal disease

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Neisseria meningitidis: pathogenesis and immunity

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Second hand smoke exposure and the risk of invasive meningococcal disease in children: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): lessons from past programs and implications for the future

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults: Recommendations of the Advisory Committee on Immunization Practices, 2015.

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

An overview of meningococcal disease in India: knowledge gaps and potential solutions

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

The current situation of meningococcal disease in Latin America and recommendations for a new case definition from the Global Meningococcal Initiative

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Evolving meningococcal immunization strategies

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

The current situation of meningococcal disease in Latin America and updated Global Meningococcal Initiative (GMI) recommendations

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Global Meningococcal Initiative: guidelines for diagnosis and confirmation of invasive meningococcal disease

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Meningococcal Disease: Epidemiology and Early Effects of Immunization Programs

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Prevalence, Risk Factors and Molecular Characteristics of Meningococcal Carriage Among Brazilian Adolescents.

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Carriage rate and effects of vaccination after outbreaks of serogroup C meningococcal disease, Brazil, 2010.

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Global epidemiology of invasive meningococcal disease

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Isolation of Neisseria meningitidis from healthy persons in Japan

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Meningococcal carriage rates in healthy individuals in Japan determined using Loop-Mediated Isothermal Amplification and oral throat wash specimens

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Present situation and challenges of vaccinations for overseas travelers from Japan

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Effectiveness of meningococcal serogroup C vaccine programmes

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Emergence of endemic serogroup W135 meningococcal disease associated with a high mortality rate in South Africa

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Increased incidence of meningococcal disease in HIV-infected individuals associated with higher case-fatality ratios in South Africa

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Risk of invasive meningococcal disease in children and adults with HIV in England: a population-based cohort study.

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

The changing epidemiology of meningococcal disease in North America 1945-2010.

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study [corrected].

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Meningococcal carriage in adolescents in the United Kingdom to inform timing of an adolescent vaccination strategy

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Molecular characterization of invasive meningococcal isolates from countries in the African meningitis belt before introduction of a serogroup A conjugate vaccine

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Whole-Genome Characterization of Epidemic Neisseria meningitidis Serogroup C and Resurgence of Serogroup W, Niger, 2015

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Meningococcal Meningitis Surveillance in the African Meningitis Belt, 2004-2013.

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Modeling Long-term Vaccination Strategies With MenAfriVac in the African Meningitis Belt

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Sequential outbreaks due to a new strain of Neisseria meningitidis serogroup C in northern Nigeria, 2013-14

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Serogroup W135 meningococcal disease in Hajj pilgrims.

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Neisseria meningitidis serogroups W135 and A were equally prevalent among meningitis cases occurring at the end of the 2001 epidemics in Burkina Faso and Niger

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Neisseria meningitidis serogroup W135 in Portugal: presence of the ST-11/ET-37 clonal complex.

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Phenotypic and molecular characterization of invasive serogroup W135 Neisseria meningitidis strains from 1990 to 2005 in Brazil

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

[Emergence of W135 meningococcal serogroup in Chile during 2012].

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Serogroup W meningococcal disease: global spread and current affect on the Southern Cone in Latin America

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Genomic Epidemiology of Hypervirulent Serogroup W, ST-11 Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Increase in endemic Neisseria meningitidis capsular group W sequence type 11 complex associated with severe invasive disease in England and Wales

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Bivalent rLP2086 Vaccine (Trumenba(®)): A Review in Active Immunization Against Invasive Meningococcal Group B Disease in Individuals Aged 10-25 Years

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Could the multicomponent meningococcal serogroup B vaccine (4CMenB) control Neisseria meningitidis capsular group X outbreaks in Africa?

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

First Use of a Serogroup B Meningococcal Vaccine in the US in Response to a University Outbreak

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

MATS: Global coverage estimates for 4CMenB, a novel multicomponent meningococcal B vaccine

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Characterization of invasive Neisseria meningitidis strains from Québec, Canada, during a period of increased serogroup B disease, 2009-2013: phenotyping and genotyping with special emphasis on the non-carbohydrate protein vaccine targets

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Impact of MenBvac, an outer membrane vesicle (OMV) vaccine, on the meningococcal carriage

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Reassessing the cost-effectiveness of meningococcal serogroup C conjugate (MCC) vaccines using a transmission dynamic model

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Introducing vaccination against serogroup B meningococcal disease: an economic and mathematical modelling study of potential impact

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Global epidemiology of capsular group W meningococcal disease (1970-2015): Multifocal emergence and persistence of hypervirulent sequence type (ST)-11 clonal complex

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs.

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Evolutionary Events Associated with an Outbreak of Meningococcal Disease in Men Who Have Sex with Men.

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1258308

21 January 2018

Identifiers

10.1080/14760584.2017.1258308

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40461214&oldid=1777325158"